Başer, OnurKeshishian, AXie, LinWang, Yuexi2019-02-282019-02-282019-02-282019-02-282016Keshishian, A., Wang, Y., Xie, L., & Baser, O. (2016). The economic impact of symptomatic menopause among low-socioeconomic women in the United States. Expert Review of Pharmacoeconomics & Outcomes Research, 16, 2, 305-13.1744-83791473-7167http://dx.doi.org/10.1586/14737167.2015.1073589https://hdl.handle.net/20.500.11779/654Onur Başer (MEF Author)Background: Menopausal symptoms have a significant negative impact on patient's quality of life and increase healthcare costs among women. Methods: This retrospective analysis used data from a U.S. national database (01 January 2008-31 December 2010). Patients with a diagnosis of menopause symptoms or a prescription claim for hormone therapy were matched to control patients. Healthcare resource utilization and costs during the 6-month follow-up period were compared. Generalized linear models were used to adjust for differences in baseline and demographic characteristics between the cohorts. Results: A total of 71,076 patients were included in each cohort. Patients with menopausal symptoms were more likely to have depression and anxiety and incurred significantly higher follow-up healthcare costs ($7237 vs $6739, p < 0.001) and healthcare utilization during the 6-month follow-up period. Conclusion: Patients diagnosed with menopausal symptoms or treated with hormone therapy incurred significantly higher healthcare costs than those without menopausal symptoms or treatment.eninfo:eu-repo/semantics/closedAccessMenopauseHormone therapyOutcomes researchArticle10.1586/14737167.2015.1073589262897322-s2.0-84938613606Q3Q2313305216WOS:000372821600001